| CAS: | 550-99-2 | |||||||||||||||||||||
| 分子式: | C14H14N2·HCl | |||||||||||||||||||||
| 分子量: | 246.74 | |||||||||||||||||||||
| 熔点: | 254-260℃ | |||||||||||||||||||||
| 中文名称: |
| |||||||||||||||||||||
| 英文名称: |
| |||||||||||||||||||||
| 性质描述: | 白色结晶性粉末。熔点255-260℃。在100毫升水中可溶解本品40克。易溶于乙醇,微溶于氯仿,不溶于苯和乙醚。无臭,味苦。 | |||||||||||||||||||||
| 生产方法: | 由α-萘乙酸与乙二胺缩合、环合制成2-(1-萘甲基)咪唑啉(C14H14N2,[835-31-4]),然后成盐而得萘甲唑啉盐酸盐。将α-乙酸和乙二胺加入反应锅内,搅拌加热至120℃,反应1小时后,再升温至130℃,反应1小时。蒸除乙二胺和水后进行减压蒸馏,收集180-240℃(1.33-4千帕)馏分,得2-(1-萘甲基)咪唑啉。然后将其溶于丙酮和乙醇的混合液,在10-12℃通入氯化氢气体成盐,即生成萘甲唑啉盐酸盐结晶。 | |||||||||||||||||||||
| 用途: | 本品为血管收缩药。大鼠皮下注射LD50为385毫克/公斤。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| N792702 | MACKLIN | 萘甲唑啉盐酸盐 | 10mM in DMSO | 428元/1ml; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N814855 | MACKLIN | 萘甲唑啉盐酸盐 | 99% | 30元/5g; 83元/25g; 299元/100g; 1485元/500g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
储存: 室温,干燥,密封 状态:白色到灰白色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N0542 | TCI | Naphazoline Hydrochloride | >99.0%(T) | 310元/10G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
技术规格
物性(参考值)
安全信息
相关法规
运输信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 506932 | J&K | Naphazoline Hydrochloride | 99%, 一种眼血管收缩剂, 是咪唑啉衍生物 | 336元/25G; 1007元/100G; 4029元/500G; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息
产品描述 Naphazoline HCl 是一种眼部血管收缩剂,是咪唑啉衍生的拟交感胺类。 靶点(IC50 & Targe) Adrenergic Receptor 安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| B24161 | Alfa Aesar | 2-(1-Naphthylmethyl)-2-imidazoline hydrochloride | 99% | 796元/25g; 2373元/100g; 9495元/500g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
应用 备注 基本信息 MDL EINECS 分子式 分子量 熔点 灵敏度 形态 溶解性 Beilstein Merck GHS危害和防范说明 GHS符号 Hazard Statements Precautionary Statements 安全信息 危险等级 包装组 危险类别 安全等级 RTECS TSCA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| C17966 | Alfa Aesar | 2-(1-Naphthylmethyl)-2-imidazoline hydrochloride | 99% | 1166元/25g; 3637元/100g; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
基本信息 Ref# MDL 分子式 分子量 安全信息 危险等级 包装组 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1457006 | USP | Naphazoline Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 α-肾上腺素受体激动剂;咪唑啉受体激动剂;血管收缩剂。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N0080000 | Naphazoline Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 α-肾上腺素受体激动剂;咪唑啉受体激动剂;血管收缩剂。 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N5504 | Sigma-Aldrich | Naphazoline Hydrochloride | 877.11元/25 G; | 展开 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 盐酸萘甲唑啉是一种拟交感神经药。它也被认为是一种结膜减充血剂。 特点和优势 该化合物由Allergan开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PHR1836 | Supelco | Naphazoline Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Materialr | 1518.26元/500 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 生化/生理作用 α-肾上腺素受体激动剂;咪唑啉受体激动剂;血管收缩剂。 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC2111 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||